Bone mineral density in women with depression

被引:352
作者
Michelson, D
Stratakis, C
Hill, L
Reynolds, J
Galliven, E
Chrousos, G
Gold, P
机构
[1] NIMH,CLIN NEUROENDOCRINOL BRANCH,BETHESDA,MD 20892
[2] NICHHD,DEV ENDOCRINOL BRANCH,BETHESDA,MD 20892
[3] GEORGETOWN UNIV,CHILDRENS MED CTR,DIV GENET,WASHINGTON,DC 20007
关键词
D O I
10.1056/NEJM199610173351602
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Depression is associated with alterations in behavior and neuroendocrine systems that are risk factors for decreased bone mineral density. This study was undertaken to determine whether women with past or current major depression have demonstrable decreases in bone density. Methods We measured bone mineral density at the hip, spine, and radius in 24 women with past or current major depression and 24 normal women matched for age, body-mass index, menopausal status, and race, using dual-energy x-ray absorptiometry. We also evaluated cortisol and growth hormone secretion, bone metabolism, and vitamin D-receptor alleles. Results AS compared with the normal women, the mean (+/- SD) bone density in the women with past or current depression was 6.5 percent lower at the spine (1.00 +/- 0.15 vs. 1.07 +/- 0.09 g per square centimeter, P=0.02), 13.6 percent lower at the femoral neck (0.76 +/- 0.11 vs, 0.88 +/- 0.11 g per square centimeter, P<0.001), 13.6 percent lower at Ward's triangle (0.70 +/- 0.14 vs. 0.81 +/- 0.13 g per square centimeter, P<0.001), and 10.8 percent lower at the trochanter (0.66+/-0.11 vs. 0.74+/-0.08 g per square centimeter, P<0.001), In addition, women with past or current depression had higher urinary cortisol excretion (71 +/- 29 vs. 51 +/- 19 mu g per day [196 +/- 80 vs. 141 +/- 52 nmol per day], P=0.006), lower serum osteocalcin concentrations (P=0.04), and lower urinary excretion of deoxypyridinoline (P=0.02). Conclusions Past or current depression in women is associated with decreased bone mineral density (C) 1996, Massachusetts Medical Society.
引用
收藏
页码:1176 / 1181
页数:6
相关论文
共 30 条
[1]   OSTEOPOROSIS AND SCHIZOPHRENIA - CAN WE LIMIT KNOWN RISK-FACTORS [J].
ABRAHAM, G ;
FRIEDMAN, RH ;
VERGHESE, C ;
DELEON, J .
BIOLOGICAL PSYCHIATRY, 1995, 38 (02) :131-132
[2]  
ALEKEL L, 1995, MED SCI SPORT EXER, V27, P1477
[3]   THE ANTIDEPRESSANTS FLUOXETINE, IDAZOXAN AND PHENELZINE ALTER CORTICOTROPIN-RELEASING HORMONE AND TYROSINE-HYDROXYLASE MESSENGER-RNA LEVELS IN RAT-BRAIN - THERAPEUTIC IMPLICATIONS [J].
BRADY, LS ;
GOLD, PW ;
HERKENHAM, M ;
LYNN, AB ;
WHITFIELD, HJ .
BRAIN RESEARCH, 1992, 572 (1-2) :117-125
[4]   LONG-TERM ANTIDEPRESSANT ADMINISTRATION ALTERS CORTICOTROPIN-RELEASING HORMONE, TYROSINE-HYDROXYLASE, AND MINERALOCORTICOID RECEPTOR GENE-EXPRESSION IN RAT-BRAIN - THERAPEUTIC IMPLICATIONS [J].
BRADY, LS ;
WHITFIELD, HJ ;
FOX, RJ ;
GOLD, PW ;
HERKENHAM, M .
JOURNAL OF CLINICAL INVESTIGATION, 1991, 87 (03) :831-837
[5]   COMPARING MARGINAL TOTALS OF SQUARE CONTINGENCY TABLES [J].
FLEISS, JL ;
EVERITT, BS .
BRITISH JOURNAL OF MATHEMATICAL & STATISTICAL PSYCHOLOGY, 1971, 24 (MAY) :117-&
[6]   RESPONSES TO CORTICOTROPIN-RELEASING HORMONE IN THE HYPERCORTISOLISM OF DEPRESSION AND CUSHINGS-DISEASE - PATHOPHYSIOLOGIC AND DIAGNOSTIC IMPLICATIONS [J].
GOLD, PW ;
LORIAUX, DL ;
ROY, A ;
KLING, MA ;
CALABRESE, JR ;
KELLNER, CH ;
NIEMAN, LK ;
POST, RM ;
PICKAR, D ;
GALLUCCI, W ;
AVGERINOS, P ;
PAUL, S ;
OLDFIELD, EH ;
CUTLER, GB ;
CHROUSOS, GP .
NEW ENGLAND JOURNAL OF MEDICINE, 1986, 314 (21) :1329-1335
[7]   CLINICAL AND BIOCHEMICAL MANIFESTATIONS OF DEPRESSION .1. RELATION TO THE NEUROBIOLOGY OF STRESS [J].
GOLD, PW ;
GOODWIN, FK ;
CHROUSOS, GP .
NEW ENGLAND JOURNAL OF MEDICINE, 1988, 319 (06) :348-353
[8]   CLINICAL AND BIOCHEMICAL MANIFESTATIONS OF DEPRESSION - RELATION TO THE NEUROBIOLOGY OF STRESS .2. [J].
GOLD, PW ;
GOODWIN, FK ;
CHROUSOS, GP .
NEW ENGLAND JOURNAL OF MEDICINE, 1988, 319 (07) :413-420
[9]  
Gold PW, 1988, NEW ENGL J MED, V319, P1428
[10]   DECREASED BONE-MINERAL DENSITY IN MEDICATED PSYCHIATRIC-PATIENTS [J].
HALBREICH, U ;
ROJANSKY, N ;
PALTER, S ;
HRESHCHYSHYN, M ;
KREEGER, J ;
BAKHAI, Y ;
ROSAN, R .
PSYCHOSOMATIC MEDICINE, 1995, 57 (05) :485-491